ReviewInternational journal of medical sciences2026
Reprogramming of Human Limbal Niche Progenitors.
Review in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Limbal niche cells (LNCs) possess embryonic stem cell (ESC) characteristics, expressing ESC markers such as Sox2, Nanog, and Oct4; stromal characteristics, expressing neurocrest markers such as CD90; and have angiogenic potential expressing angiogenesis markers such as CD34. In addition, these cells can be induced into adipocytes, chondrocytes, and osteocytes, indicating that they are valuable adult stem cells. However, how these cells may be appropriately passaged and maintained, what signaling pathways are necessary for such regeneration, and how the cells can be used for the treatment of various diseases caused by stem cell deficiency, such as limbal stem cell deficiency, remain unclear. Herein, we summarize the most recent advances in limbal niche research, with emphasis on the regeneration of adult limbal progenitors and their mechanisms, to promote cell-based therapy for various eye diseases due to stem cell deficiency or malfunction. Such a strategy may also provide a platform for stem cell therapy for other similar human diseases worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.